Table 3.

Characterization of MSC from various tissues based on surface markers

Tissue	Positive markers	Negative markers
Bone marrow	CD29, CD31, CD44, CD49a, CD49b, CD49c, CD49d, CD49e, CD51, CD54, CD58, CD61, CD71, CD73, CD90, CD102, CD104, CD105, CD106, CD120a, CD120b, CD121a, CD124, CD146, CD166, CD221, CD271, SSEA-4, STRO-1 [56]	CD11a, CD11b, CD13, CD14, CD19,CD34, CD45, CD133 [56]
Adipose tissue	CD105, CD73, CD36, CD90, CD44, CD29, CD151, CD49d, CD44 [55, 57, 58]	CD45, CD34, CD14, CD11b, CD19, HLA-DR, CD34, CD38, CD31, CD106 [55, 57, 58]
Synovial fluid	CD9, CD10, CD13, CD44, CD54, CD55, CD90, CD105, CD166, D7-FIB, CD49a, CD147, CD73, PDGFRα (CD140a) [59]	CD14, CD45, CD34, CD117, CD62e, CD20, CD113, HLA-DR, CD68, CD31, ALP [59]
Dental pulp	CD29, CD44, CD105, CD146, CD117 and STRO-1 [60], SSEA-4, CD146, CD73, CD44, CD10, CD123 [61]	HLA-DR, CD106, CD34,CD7,CD31 [61]
Amnion	CD73, CD29, CD49f, Oct4, Nanog, Sox2, SSEA-3, SSEA-4, Rex1 [62]	CD14, CD20, CD34, CD45 [63]